CUV

1.61%

$14.68 clinuvel pharmaceuticals limited

Ann: CLINUVEL expands global leadership team, page-5

First 5 Last

Share
Profile

Follow
ben1976

133 Posts.

23

22/04/24

11:49

Post #: 73454531
Share

Originally posted by Silverchair: ↑

Good appointments. Dr Rodenburger helped achieve the FDA approval for Clinuvel in the past with EPP, also knows Vitiligo and obtaining FDA approval in this blockbuster should be easier as the drug is already approved with a long track record of safety and showing efficacy would appear to be quite simple relatively. Approval for a new indication easier than a whole new drug application, with safety well established, so hopefully this becomes the standard of care in just a handful of years.

US investor relations also good, first job needs to be the basic upgrade from the obscure pink sheets so attracting investors will be an easier task for him. Clinuvel said it only took one investor buying a lot of shares in Sep 2021 to take the price over $40 and the investment case is much stronger now with the Phase 3 trial running and stated revenue targets of $490 - $570 Million USD in years 1-2 on top of an already very profitable enterprise which doesn't have to share profits with 'big Pharma'. Great scenario just calculate likelihood of Vitiligo approval, pretty good chance IMO and only one analyst has done this and come up with a PT ~$50. Mega Blockbuster Stroke and everything else you get for free with CUV and many small loss making Biotechs with high valuations just on the hope that their Phase 1 or 2 will one day become a blockbuster like Stroke.

Not using the buyback at all is quite ridiculous, they had good momentum with the announcement and follow up statement that the buyback would be expanded if shorters didn't 'get the message' and then great news potential competitor Disc flunked their EPP trial. All this led to great buying and shorts had to pump in enormous amounts of fake Sell liquidity to control the price according to ASIC data. Since then they have continued to drop the price like last Friday, a 6% drop which was 3% below VWAP shows massive manipulation designed to scare investors, shorts have a clear history with doing this at CUV and the company just let it happen last week when they have the tools to stop this now (over time). Still manipulating the closing price to 3% below VWAP might even be enough to attract ASIC attention if they have any heartbeat at all but that is a long shot - still the shorting game is stacked in favour of shorters they can take 6% off with fake liquidity and circular trades in one day but CUV can only buyback up to a limit of 5% above previous 5 days average VWAP. That is why the buyback will work over time but it needs to get moving with some aggression and then maintain that momentum (and maybe management buying would also send a signal). Either way it's a great entry point for new investors and should make new US recruit Mr Clouston's job quite easy in the States. It shouldn't take too many large investors to get this thing moving, unless shorters want to make cash printing CUV the most shorted company in Australia against all logic.

All IMO DYOR

Expand

Is there buy volume restriction(based on average volume sold ) or only VWAP 5% restriction for Buy back?

CUV Price at posting: $14.38 Sentiment: Buy Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

BOE

Uranium prices on the NYMEX are stable, but ASX uranium stocks are sinking on Friday. The answer lies in Kazakhstan

DVP

Commodity house Trafigura funds Develop Global's copper-zinc Woodlawn play with offtake deal in place

Week 31 Wrap: JORC rules to get tougher; RBA rate hike chance 50/50; US Fed Sept cut still the quo

GRX

GreenX picks up prospective copper project in Germany

VMT

Vmoto sales plummet -50% YoY as weak demand in Europe & China stifles EV scooter sales growth

MGU

Collaboration in a green (steel) future the focus for Magnum and Saudi partners

Is oil undervalued?

VMS

Venture to sniff out high-grade REE targets at Jupiter project, WA

NXG

Cost blow-out for Rook I uranium project sees share plummet for NexGen

WGX

Westgold sets its sights on top five producer status through merger with Karora

There are more pages in this discussion • 6 more messages in this thread...

First 5 Last

Add CUV (ASX) to my watchlist

(20min delay)
Last $14.68		Change -0.240(1.61%)		Mkt cap ! $735.1M

Open	High	Low	Value	Volume
$14.75	$14.92	$14.65	$503.5K	34.18K

Buyers (Bids)

No.	Vol.	Price($)
1	448	$14.68

Sellers (Offers)

Price($)	Vol.	No.
$14.74	149	1

View Market Depth

No.	Vol.	Price($)
1	448	14.680
1	340	14.600
2	1069	14.560
1	2000	14.520
1	500	14.500

Price($)	Vol.	No.
14.980	1000	1
15.150	519	1
15.180	100	1
15.190	50	1
15.200	47	1

Last trade - 16.10pm 02/08/2024 (20 minute delay)

CUV (ASX) Chart

Ann: CLINUVEL expands global leadership team, page-5

Uranium prices on the NYMEX are stable, but ASX uranium stocks are sinking on Friday. The answer lies in Kazakhstan

Commodity house Trafigura funds Develop Global's copper-zinc Woodlawn play with offtake deal in place

Week 31 Wrap: JORC rules to get tougher; RBA rate hike chance 50/50; US Fed Sept cut still the quo

GreenX picks up prospective copper project in Germany

Vmoto sales plummet -50% YoY as weak demand in Europe & China stifles EV scooter sales growth

Collaboration in a green (steel) future the focus for Magnum and Saudi partners

Is oil undervalued?

Venture to sniff out high-grade REE targets at Jupiter project, WA

Cost blow-out for Rook I uranium project sees share plummet for NexGen

Westgold sets its sights on top five producer status through merger with Karora

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: CLINUVEL expands global leadership team, page-5

Top Stories

Uranium prices on the NYMEX are stable, but ASX uranium stocks are sinking on Friday. The answer lies in Kazakhstan

Commodity house Trafigura funds Develop Global's copper-zinc Woodlawn play with offtake deal in place

Week 31 Wrap: JORC rules to get tougher; RBA rate hike chance 50/50; US Fed Sept cut still the quo

GreenX picks up prospective copper project in Germany

Vmoto sales plummet -50% YoY as weak demand in Europe & China stifles EV scooter sales growth

Collaboration in a green (steel) future the focus for Magnum and Saudi partners

Is oil undervalued?

Venture to sniff out high-grade REE targets at Jupiter project, WA

Cost blow-out for Rook I uranium project sees share plummet for NexGen

Westgold sets its sights on top five producer status through merger with Karora

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News